Sierra Summit Advisors LLC Invests $730,000 in Option Care Health, Inc. $OPCH

Sierra Summit Advisors LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 26,287 shares of the company’s stock, valued at approximately $730,000.

Other hedge funds also recently bought and sold shares of the company. Intech Investment Management LLC raised its holdings in shares of Option Care Health by 54.2% during the third quarter. Intech Investment Management LLC now owns 188,167 shares of the company’s stock valued at $5,224,000 after acquiring an additional 66,167 shares during the period. Fox Run Management L.L.C. purchased a new position in Option Care Health during the 3rd quarter worth approximately $1,309,000. Colonial Trust Co SC acquired a new stake in Option Care Health during the 3rd quarter valued at $56,000. AXQ Capital LP lifted its holdings in shares of Option Care Health by 256.2% in the third quarter. AXQ Capital LP now owns 40,092 shares of the company’s stock valued at $1,113,000 after purchasing an additional 28,836 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Option Care Health by 73.9% in the third quarter. EverSource Wealth Advisors LLC now owns 2,447 shares of the company’s stock valued at $68,000 after purchasing an additional 1,040 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Up 1.8%

OPCH opened at $32.46 on Monday. The firm has a market cap of $5.08 billion, a P/E ratio of 25.36, a price-to-earnings-growth ratio of 1.82 and a beta of 0.85. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The business has a 50 day moving average price of $33.99 and a 200 day moving average price of $30.60. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.44 earnings per share. Research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on OPCH. Wall Street Zen downgraded Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, December 9th. Morgan Stanley upped their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. TD Cowen reaffirmed a “hold” rating on shares of Option Care Health in a research report on Tuesday, January 27th. Finally, Jefferies Financial Group restated a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a report on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.58.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.